ebomi
Colour theme
Sign in
Insider · CIK 0001770790

Lamond David

CIK 0001770790 Name as filed on the most recent filing

Filed as Lamond David (11)

35 transaction lines · from 11 filings · filed 2020-05-19 to 2023-12-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

35 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2023-12-14 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 22,627 acquired 1.04 23,532.08 Form 4, filing 0001209191-23-058694
2023-12-13 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 22,627 acquired 1.00 22,627.00 Form 4, filing 0001209191-23-058694
2023-12-12 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 22,327 acquired 1.02 22,773.54 Form 4, filing 0001209191-23-058694
2023-12-12 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 300 acquired 1.00 300.00 Form 4, filing 0001209191-23-058694
2023-12-07 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 19,123 acquired 1.01 19,314.23 Form 4, filing 0001209191-23-057799
2023-12-06 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 19,123 acquired 1.02 19,505.46 Form 4, filing 0001209191-23-057799
2023-12-05 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 19,123 acquired 1.01 19,314.23 Form 4, filing 0001209191-23-057799
2023-12-01 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 14,378 acquired 0.94 13,515.32 Form 4, filing 0001209191-23-057053
2023-11-30 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 14,378 acquired 0.90 12,940.20 Form 4, filing 0001209191-23-057053
2023-11-29 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 14,378 acquired 0.98 14,090.44 Form 4, filing 0001209191-23-057053
2023-08-31 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 41,026 acquired 1.32 54,154.32 Form 4, filing 0001209191-23-047880
2023-08-30 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 41,026 acquired 1.31 53,744.06 Form 4, filing 0001209191-23-047880
2023-08-17 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 24,766 acquired 1.29 31,948.14 Form 4, filing 0001209191-23-046402
2023-08-16 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 117,348 acquired 1.29 151,378.92 Form 4, filing 0001209191-23-046402
2023-08-15 Quince Therapeutics, Inc.
QNCX 		P, Open-market purchase 107,886 acquired 1.32 142,409.52 Form 4, filing 0001209191-23-046402
2022-05-23 Applied Molecular Transport Inc.
AMTI 		P, Open-market purchase 33,500 acquired 3.26 109,210.00 Form 4, filing 0001209191-22-031435
2022-05-20 Applied Molecular Transport Inc.
AMTI 		P, Open-market purchase 33,000 acquired 3.08 101,640.00 Form 4, filing 0001209191-22-031435
2021-04-06 Applied Molecular Transport Inc.
AMTI 		P, Open-market purchase 25,000 acquired 42.00 1,050,000.00 Form 4, filing 0001209191-21-025973
2021-03-24 Cortexyme, Inc.
CRTX 		P, Open-market purchase 50,000 acquired 33.77 1,688,500.00 Form 4, filing 0001209191-21-022947
2021-03-04 Cortexyme, Inc.
CRTX 		P, Open-market purchase 16,621 acquired 34.28 569,767.88 Form 4, filing 0001209191-21-018328
2021-03-04 Cortexyme, Inc.
CRTX 		P, Open-market purchase 15,969 acquired 36.34 580,313.46 Form 4, filing 0001209191-21-018328
2021-03-04 Cortexyme, Inc.
CRTX 		P, Open-market purchase 13,310 acquired 35.00 465,850.00 Form 4, filing 0001209191-21-018328
2021-03-04 Cortexyme, Inc.
CRTX 		P, Open-market purchase 4,100 acquired 36.86 151,126.00 Form 4, filing 0001209191-21-018328
2020-06-04 Cortexyme, Inc.
CRTX 		P, Open-market purchase 24,874 acquired 43.88 1,091,384.06 Form 4, filing 0001209191-20-035104
2020-06-04 Cortexyme, Inc.
CRTX 		P, Open-market purchase 13,609 acquired 42.13 573,377.11 Form 4, filing 0001209191-20-035104
2020-06-04 Cortexyme, Inc.
CRTX 		P, Open-market purchase 10,642 acquired 43.32 461,033.79 Form 4, filing 0001209191-20-035104
2020-05-19 Cortexyme, Inc.
CRTX 		P, Open-market purchase 32,894 acquired 56.42 1,855,738.04 Form 4, filing 0001209191-20-030688
2020-05-19 Cortexyme, Inc.
CRTX 		P, Open-market purchase 5,906 acquired 55.42 327,308.75 Form 4, filing 0001209191-20-030688
2020-05-19 Cortexyme, Inc.
CRTX 		P, Open-market purchase 400 acquired 54.09 21,636.00 Form 4, filing 0001209191-20-030688
2020-05-15 Cortexyme, Inc.
CRTX 		P, Open-market purchase 1,600 acquired 48.96 78,333.44 Form 4, filing 0001209191-20-030688
2020-05-15 Cortexyme, Inc.
CRTX 		P, Open-market purchase 1,263 acquired 46.30 58,477.78 Form 4, filing 0001209191-20-030688
2020-05-15 Cortexyme, Inc.
CRTX 		P, Open-market purchase 1,000 acquired 50.71 50,707.30 Form 4, filing 0001209191-20-030688
2020-05-15 Cortexyme, Inc.
CRTX 		P, Open-market purchase 985 acquired 48.36 47,639.52 Form 4, filing 0001209191-20-030688
2020-05-15 Cortexyme, Inc.
CRTX 		P, Open-market purchase 500 acquired 52.20 26,100.50 Form 4, filing 0001209191-20-030688
2020-05-15 Cortexyme, Inc.
CRTX 		P, Open-market purchase 100 acquired 53.10 5,310.00 Form 4, filing 0001209191-20-030688

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 35
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Lamond David, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001770790

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.